(Q39544471)

English

Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling

scientific article published on 26 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

neovascularization

1 reference

based on heuristic

inferred from title

reactive oxygen species

1 reference

based on heuristic

inferred from title

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

author name string

Sung Wook Park

1

1 reference

Europe PubMed Central

12 September 2017

Hyoung Oh Jun

2

1 reference

Europe PubMed Central

12 September 2017

Euna Kwon

3

1 reference

Europe PubMed Central

12 September 2017

Jun-Won Yun

4

1 reference

Europe PubMed Central

12 September 2017

Jin Hyoung Kim

5

1 reference

Europe PubMed Central

12 September 2017

Young-Jun Park

6

1 reference

Europe PubMed Central

12 September 2017

Byeong-Cheol Kang

7

1 reference

Europe PubMed Central

12 September 2017

Jeong Hun Kim

8

1 reference

Europe PubMed Central

12 September 2017

publication date

26 July 2016

1 reference

Europe PubMed Central

12 September 2017

Vascular Pharmacology

1 reference

Europe PubMed Central

12 September 2017

90

1 reference

Europe PubMed Central

12 September 2017

19-26

1 reference

Europe PubMed Central

12 September 2017

How to overcome retinal neuropathy: the fight against angiogenesis-related blindness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Basic and therapeutic aspects of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

VEGF signaling through NADPH oxidase-derived ROS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Redox signaling in angiogenesis: role of NADPH oxidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

On the possible role of reactive oxygen species in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Betaine in human nutrition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Anti-angiogenic effect of caffeic acid on retinal neovascularization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1α.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Absence of intravitreal bevacizumab-induced neuronal toxicity in the retina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Mitochondrial UQCRB regulates VEGFR2 signaling in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Oxidative protein damage in human diabetic eye: evidence of a retinal participation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Angiogenesis inhibited by drinking tea.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.07.007

7 January 2021

Identifiers

10.1016/J.VPH.2016.07.007

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39544471&oldid=2098017969"